Jakavi 15mg

Description

Jakavi 15mg tablets contain ruxolitinib,

a kinase inhibitor used to treat Jakavi 15mg ONLINE specific blood cancers.

(myelofibrosis, polycythaemia vera) and Jakavi 15mg PRICE graft-versus-host disease.

(GvHD). It works by blocking JAK enzymes to reduce spleen BUY ONLINE Jakavi 15mg  size, manage symptoms like fever/night

sweats, and lower high red blood cell counts. It is a prescription drug with serious risks.

Oval-shaped, curved, white-to off-white color tablets. Debossed Imprints: On one side of the drug, there is an imprint that says “NVR” while on the other side, it imprints “L15”. Active Ingredients: Each tablet contains 15 mg of Ruxolitinib.Pharmacology of the Medication

Type of Drug: Ruxolitinib belongs to kinase inhibitors and specifically is an inhibitor of the JAK1 and JAK2 enzymes. Method of Action: Helps regulate dys regulated JAK-STAT signaling pathways that cause the overproduction of cells and their inflammation. Indications of Usage: Intermediate or High risk myelofibrosis, Hydroxyurea resistant polycythemia vera and Steroid refractory Graft-versus-Host disease (both Acute and Chronic).

Directions for Use: Always take the medication in the way it has been prescribed by your specialist and strictly adhere to the schedule. Take it orally in its whole form and wash it down with some water. Never cut, crush or break the tablets. You can take them with or without food.Common Side Effects of Use: Include reduced production of blood cells (anemia, thrombocytopenia, neutropenia), bruises, headaches, dizziness, and diarrhea.

Jakafi is the first medicine that got approved by the FDA for treating such patients. Jakafi is NOT chemotherapy. It is targeted therapy designed to help regulate the production.